BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24931900)

  • 1. The effect of an outpatient care on-demand-system on health status and costs in patients with COPD. A randomized trial.
    Berkhof FF; Hesselink AM; Vaessen DL; Uil SM; Kerstjens HA; van den Berg JW
    Respir Med; 2014 Aug; 108(8):1163-70. PubMed ID: 24931900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telemedicine, the effect of nurse-initiated telephone follow up, on health status and health-care utilization in COPD patients: a randomized trial.
    Berkhof FF; van den Berg JW; Uil SM; Kerstjens HA
    Respirology; 2015 Feb; 20(2):279-85. PubMed ID: 25400242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial.
    Trappenburg JC; Monninkhof EM; Bourbeau J; Troosters T; Schrijvers AJ; Verheij TJ; Lammers JW
    Thorax; 2011 Nov; 66(11):977-84. PubMed ID: 21785156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD.
    Jain VV; Allison R; Beck SJ; Jain R; Mills PK; McCurley JW; Van Gundy KP; Peterson MW
    Respir Med; 2014 Dec; 108(12):1794-800. PubMed ID: 25294691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.
    Esteban C; Quintana JM; Moraza J; Aburto M; Egurrola M; España PP; Pérez-Izquierdo J; Aguirre U; Aizpiri S; Capelastegui A
    Respir Med; 2009 Aug; 103(8):1201-8. PubMed ID: 19272762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
    Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with high healthcare resource utilisation among COPD patients.
    García-Polo C; Alcázar-Navarrete B; Ruiz-Iturriaga LA; Herrejón A; Ros-Lucas JA; García-Sidro P; Tirado-Conde G; López-Campos JL; Martínez-Rivera C; Costán-Galicia J; Mayoralas-Alises S; De Miguel-Díez J; Miravitlles M;
    Respir Med; 2012 Dec; 106(12):1734-42. PubMed ID: 23058483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Wakabayashi R; Kida K
    Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention for chronic obstructive pulmonary disease by practice nurse and GP teams: a cluster randomized trial.
    Zwar NA; Bunker JM; Reddel HK; Dennis SM; Middleton S; van Schayck OC; Crockett AJ; Hasan I; Hermiz O; Vagholkar S; Xuan W; Marks GB
    Fam Pract; 2016 Dec; 33(6):663-670. PubMed ID: 27535327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
    Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
    Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
    Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.